Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2024-07-23
HALOHalozyme Therapeutics, Inc.Labarre Michael J.SVP, CHIEF TECHNICAL OFFICERS - Sale+OE$55.00-20,000168,176-11%-$1,100,023
D
2024-07-23
PCVXVaxcyte, Inc.Pickering GrantCEOS - Sale+OE$84.26-15,000765,764-2%-$1,263,912
M
2024-07-22
ATYRAtyr Pharma IncSchimmel PaulDirP - Purchase$1.85+100,0001,101,056+10%+$184,613
D
2024-07-22
ARTVArtiva Biotherapeutics, Inc.Ra Capital Management, L.P.Dir, 10%P - Purchase$12.00+8,333,333826,832-111%+$99,999,996
D
2024-07-22
ARTVArtiva Biotherapeutics, Inc.5Am Partners Vi, LLC10%P - Purchase$12.00+833,3332,353,304+55%+$9,999,996
2024-07-19
BCLIBrainstorm Cell Therapeutics Inc.Dagher Ibrahim B.Chief Medical OfficerS - Sale$0.35-63,000190,000-25%-$22,069
D
2024-07-22
HALOHalozyme Therapeutics, Inc.Labrosse NicoleSVP, CFOS - Sale+OE$53.93-5,00015,480-24%-$269,662
M
2024-07-19
ALVRAllovir, Inc.Hagen Brett RChief Accounting OfficerS - Sale$0.74-96074,217-1%-$715
2024-07-19
ALVRAllovir, Inc.Brainard DianaCEOS - Sale$0.75-9,731773,251-1%-$7,299
M
2024-07-19
ALVRAllovir, Inc.Sinha VikasSee Remarks, 10%S - Sale$0.74-3,40017,836,7600%-$2,530
M
2024-07-19
ALVRAllovir, Inc.Miller EdwardGCS - Sale$0.74-1,391507,5250%-$1,035
D
2024-07-22
ARTVArtiva Biotherapeutics, Inc.Venbio Global Strategic Fund Iii, L.P.10%P - Purchase$12.00+416,6661,936,637+27%+$4,999,992
D
2024-07-22
ARTVArtiva Biotherapeutics, Inc.Gc Corp.10%P - Purchase$12.00+2,083,3324,567,412+84%+$24,999,984
D
2024-07-22
ARTVArtiva Biotherapeutics, Inc.Huh Yong-JunDirP - Purchase$12.00+2,083,3324,567,412+84%+$24,999,984
2024-07-19
EDITEditas Medicine, Inc.Mei BaisongEVP, CHIEF MEDICAL OFFICERS - Sale$5.21-6,619134,413-5%-$34,456
D
2024-07-18
PCVXVaxcyte, Inc.Guggenhime AndrewPres, CFOS - Sale+OE$81.17-8,00096,720-8%-$649,325
2024-07-17
MRNAModerna, Inc.Afeyan NoubarDirS - Sale$122.84-15,0006,886,1640%-$1,842,651
2024-07-17
IMVTImmunovant, Inc.Levine Mark S.GCS - Sale$29.69-2,505337,409-1%-$74,382
2024-07-17
IMVTImmunovant, Inc.Macias William L.Chief Medical OfficerS - Sale$29.69-3,044371,359-1%-$90,386
2024-07-17
IMVTImmunovant, Inc.Barnett Eva ReneeCFOS - Sale$29.69-3,123347,544-1%-$92,733
2024-07-17
IMVTImmunovant, Inc.Butchko Julia G.Chief Development OfficerS - Sale$29.69-2,867443,986-1%-$85,132
2024-07-17
IMVTImmunovant, Inc.Salzmann PeterCEOS - Sale$29.69-8,6851,023,412-1%-$257,888
DM
2024-07-17
VCELVericel CorpColangelo DominickPres, CEOS - Sale+OE$51.48-35,000220,937-14%-$1,801,625
2024-07-17
CADLCandel Therapeutics, Inc.Tyagarajan SeshuCTOS - Sale$6.47-14,851146,049-9%-$96,125
2024-07-17
CADLCandel Therapeutics, Inc.Tak Paul PeterCEOS - Sale$6.47-22,528330,735-6%-$145,815
2024-07-17
CADLCandel Therapeutics, Inc.Schoch CharlesSee RemarksS - Sale$6.47-9,88462,520-14%-$63,975
2024-07-17
CADLCandel Therapeutics, Inc.Nichols William GarrettChief Medical OfficerS - Sale$6.47-10,875114,482-9%-$70,390
2024-07-17
CADLCandel Therapeutics, Inc.Barone FrancescaChief Scientific OfficerS - Sale$6.47-14,051159,961-8%-$90,947
M
2024-07-17
ADVMAdverum Biotechnologies, Inc.Leonard Braden Michael10%P - Purchase$8.26+216,2642,287,064+10%+$1,785,662
D
2024-07-16
FDMT4D Molecular Therapeutics, Inc.Bizily ScottGCS - Sale+OE$27.11-1,7506,781-21%-$47,443
D
2024-07-16
ACLXArcellx, Inc.Heery ChristopherCHIEF MEDICAL OFFICERS - Sale+OE$65.30-10,9019,278-54%-$711,854
D
2024-07-16
NBIXNeurocrine Biosciences IncCooke JulieCHROS - Sale+OE$150.04-90018,202-5%-$135,036
DM
2024-07-16
RGNXRegenxbio Inc.Mills Kenneth T.DirS - Sale+OE$13.77-2,410408,035-1%-$33,192
D
2024-07-16
NBIXNeurocrine Biosciences IncDelaet IngridChief Regulatory OfficerS - Sale+OE$150.03-2,8576,607-30%-$428,627
D
2024-07-16
NBIXNeurocrine Biosciences IncLyons Gary ADirS - Sale+OE$150.03-930119,047-1%-$139,530
D
2024-07-16
NBIXNeurocrine Biosciences IncAbernethy MattCFOS - Sale+OE$150.04-90031,528-3%-$135,037
D
2024-07-16
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale+OE$150.00-7,00439,740-15%-$1,050,590
D
2024-07-16
VCELVericel CorpFlynn Sean C.GCS - Sale+OE$52.18-15,000707-95%-$782,700
2024-07-16
TARAProtara Therapeutics, Inc.Opaleye Management Inc.10%S - Sale$2.44-11,3962,210,027-1%-$27,828
D
2024-07-15
RVMDRevolution Medicines, Inc.Kelsey Stephen MichaelSee RemarksS - Sale+OE$46.47-16,667269,073-6%-$774,516
D
2024-07-16
PCVXVaxcyte, Inc.Cowan ElviaSVP, FinanceS - Sale+OE$85.00-5,00012,723-28%-$425,000
DM
2024-07-15
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerS - Sale+OE$45.53-39,60095,470-29%-$1,803,143
D
2024-07-12
RVMDRevolution Medicines, Inc.Goldsmith Mark ASee RemarksS - Sale+OE$45.04-35,000802,913-4%-$1,576,322
2024-07-15
MRNAModerna, Inc.Hoge StephenPresS - Sale$121.12-15,0001,598,138-1%-$1,816,800
2024-07-12
VCELVericel CorpMara Joseph Anthony JrCFOS - Sale$50.00-5,00014,436-26%-$250,000
D
2024-07-11
FDMT4D Molecular Therapeutics, Inc.Bizily ScottGCS - Sale+OE$25.00-1,9966,781-23%-$49,900
2024-07-11
CADLCandel Therapeutics, Inc.Tyagarajan SeshuCTOS - Sale$5.97-13,330160,900-8%-$79,625
2024-07-11
CADLCandel Therapeutics, Inc.Tak Paul PeterCEOS - Sale$5.97-20,293353,263-5%-$121,218
2024-07-11
CADLCandel Therapeutics, Inc.Schoch CharlesSee RemarksS - Sale$5.97-8,89772,404-11%-$53,145
2024-07-11
CADLCandel Therapeutics, Inc.Nichols William GarrettChief Medical OfficerS - Sale$5.97-9,769125,357-7%-$58,354
2024-07-11
CADLCandel Therapeutics, Inc.Barone FrancescaChief Scientific OfficerS - Sale$5.97-12,645174,012-7%-$75,534
2024-07-10
MRNAModerna, Inc.Afeyan NoubarDirS - Sale$117.08-15,0006,901,1640%-$1,756,177
DM
2024-07-10
RXRXRecursion Pharmaceuticals, Inc.Gibson ChristopherCEOS - Sale+OE$7.48-100,000758,738-12%-$747,500
DM
2024-07-11
ACLXArcellx, Inc.Heery ChristopherCHIEF MEDICAL OFFICERS - Sale+OE$60.08-5,4519,278-37%-$327,477
D
2024-07-10
FDMT4D Molecular Therapeutics, Inc.Kirn DavidCEOS - Sale+OE$22.49-12,9231,059,153-1%-$290,598
DM
2024-07-10
LXEOLexeo Therapeutics, Inc.Townsend Richard NolanCEOS - Sale+OE$16.79-55,000120,695-31%-$923,388
M
2024-07-09
TARAProtara Therapeutics, Inc.Opaleye Management Inc.10%S - Sale$2.36-74,5512,221,423-3%-$175,842
DM
2024-07-09
RXRXRecursion Pharmaceuticals, Inc.Secora MichaelCFOS - Sale+OE$7.28-30,0001,316,593-2%-$218,354
2024-07-09
RXRXRecursion Pharmaceuticals, Inc.Borgeson BlakeDirS - Sale$7.32-11,4477,167,1100%-$83,735
2024-07-09
TWSTTwist Bioscience CorpLaponis AdamCFOS - Sale$48.91-84273,602-1%-$41,185
D
2024-07-09
ACLXArcellx, Inc.Patel KavitaDirS - Sale+OE$56.63-1,5000-100%-$84,947
2024-07-09
IMVTImmunovant, Inc.Barnett Eva ReneeCFOS - Sale$28.06-4,747350,667-1%-$133,201
2024-07-09
IMVTImmunovant, Inc.Butchko Julia G.Chief Development OfficerS - Sale$28.06-1,527446,8530%-$42,848
2024-07-09
IMVTImmunovant, Inc.Salzmann PeterCEOS - Sale$28.06-4,6191,032,0970%-$129,609
2024-07-09
RVMDRevolution Medicines, Inc.Cislini JeffGCS - Sale$40.83-2,39947,088-5%-$97,951
D
2024-07-09
RVMDRevolution Medicines, Inc.Patel SushilDirS - Sale+OE$44.00-2,15519,948-10%-$94,820
2024-07-05
CGEMCullinan Therapeutics, Inc.Michaelson JenniferChief Scientific OfficerS - Sale$16.33-8,000123,942-6%-$130,640
D
2024-07-08
PCVXVaxcyte, Inc.Cowan ElviaSVP, FinanceS - Sale+OE$80.00-5,00012,723-28%-$400,000
2024-07-09
KYMRKymera Therapeutics, Inc.Booth BruceDirS - Sale$38.21-453,960723,246-39%-$17,346,919
D
2024-07-08
MRNAModerna, Inc.Mock James MCFOS - Sale+OE$118.24-6897,269-9%-$81,465
2024-07-05
GLUEMonte Rosa Therapeutics, Inc.Dunn EdmundPrincipal Accounting OfficerS - Sale$3.83-1,61013,944-10%-$6,166
2024-07-05
VCELVericel CorpSiegal JonathanPrincipal Accounting OfficerS - Sale$45.00-5451,033-35%-$24,525
D
2024-07-05
FENCFennec Pharmaceuticals Inc.Rallis Chris ADirS - Sale+OE$6.03-1,17346,457-2%-$7,073
2024-07-05
APGEApogee Therapeutics, Inc.Henderson Michael ThomasCEOS - Sale$37.26-15,0001,474,487-1%-$558,900
2024-07-03
APGEApogee Therapeutics, Inc.Dambkowski CarlChief Medical OfficerS - Sale$37.60-5,995294,793-2%-$225,418
2024-07-02
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$48.00-12679,7050%-$6,048
D
2024-07-02
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$48.00-1,114504,7320%-$53,474
2024-07-02
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$48.00-32289,9740%-$15,457
2024-07-02
TWSTTwist Bioscience CorpFinn Patrick JohnPres, COOS - Sale$48.00-476173,4190%-$22,849
D
2024-07-02
DNAGinkgo Bioworks Holdings, Inc.Coen Steven P.See remarksS - Sale+OE$0.33-13,520195,058-6%-$4,408
D
2024-07-02
DNAGinkgo Bioworks Holdings, Inc.Dmytruk Mark E.See RemarksS - Sale+OE$0.33-49,1621,043,626-4%-$16,027
M
2024-06-13
DNLIDenali Therapeutics Inc.Krognes Steve E.DirS - Sale$22.11-30,688872,620-3%-$678,660
2024-07-01
DNLIDenali Therapeutics Inc.Sato Vicki LDirS - Sale$22.14-3,080119,256-3%-$68,204
D
2024-07-01
FDMT4D Molecular Therapeutics, Inc.Bizily ScottGCS - Sale+OE$21.36-4,2481,737-71%-$90,758
2024-07-02
ALVRAllovir, Inc.Miller EdwardGCS - Sale$0.72-379508,9160%-$273
2024-07-02
ALVRAllovir, Inc.Sinha VikasSee Remarks, 10%S - Sale$0.72-93917,840,1600%-$676
2024-07-02
ALVRAllovir, Inc.Hagen Brett RChief Accounting OfficerS - Sale$0.72-30475,1770%-$219
2024-07-02
ALVRAllovir, Inc.Brainard DianaCEOS - Sale$0.72-1,489782,9820%-$1,072
M
2024-07-01
BEAMBeam Therapeutics Inc.Simon AmyChief Medical OfficerS - Sale$23.28-1,25068,805-2%-$29,094
D
2024-07-01
ACLXArcellx, Inc.Heery ChristopherCHIEF MEDICAL OFFICERS - Sale+OE$55.39-20,0009,278-68%-$1,107,763
2024-07-01
TARAProtara Therapeutics, Inc.Opaleye Management Inc.10%S - Sale$2.12-8,2882,300,9740%-$17,598
D
2024-07-01
RGNXRegenxbio Inc.Karabelas Argeris NDirS - Sale+OE$11.27-10,00011,286-47%-$112,691
D
2024-07-01
NBIXNeurocrine Biosciences IncCooke JulieCHROS - Sale+OE$140.19-10,00018,202-35%-$1,401,864
D
2024-07-01
NBIXNeurocrine Biosciences IncDelaet IngridChief Regulatory OfficerS - Sale+OE$138.11-2727,507-3%-$37,566
M
2024-06-28
WENAAnew Medical, Inc.Chardan Capital Markets LLC10%S - Sale$2.12-342,1361,284,364-21%-$725,162
2024-07-02
FENCFennec Pharmaceuticals Inc.Raykov RostyCEOS - Sale$6.13-2,431187,471-1%-$14,902
D
2024-07-01
PCVXVaxcyte, Inc.Eydelman MikhailSVP, GC, Corp SecS - Sale+OE$76.37-1,66730,826-5%-$127,304
2024-07-01
PCVXVaxcyte, Inc.Wassil JimCOOS - Sale$76.34-3,000210,503-1%-$229,013
2024-07-01
PCVXVaxcyte, Inc.Pickering GrantCEOS - Sale$76.33-2,616622,3260%-$199,690
M
2024-06-28
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$3.03+50039,745+1%+$1,513

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top